Journal articles on the topic 'MDSC, CANCER IMMUNOLOGY, IMMUNOSUPPRESSION, INNATE IMMUNITY'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'MDSC, CANCER IMMUNOLOGY, IMMUNOSUPPRESSION, INNATE IMMUNITY.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Lysіаniy, Mykola, Lyudmila Belskaya, Irina Gnіdkova, and Nastya Palamaryova. "ROLE OF CELLS OF INNATE IMMUNITY IN THE DEVELOPMENT OF MALIGNANT TUMORS OF THE BRAIN." Immunology and Allergy: Science and Practice, no. 4 (December 23, 2019): 4–12. http://dx.doi.org/10.37321/immunology.2019.04-01.
Full textMorenkova, A., M. Tikhonova, T. Tyrinova, E. Batorov, A. Sizikov, O. Chumasova, A. Sulutian, V. Koksharova, D. Orlov, and E. Chernykh. "AB0059 CLINICAL SIGNIFICANCE OF CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS WITH ANKYLOSING SPONDYLITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1331.1–1331. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2998.
Full textBoda, Akash R., Casey R. Ager, Kimal Rajapakshe, Spencer T. Lea, and Michael A. Curran. "High-potency synthetic STING agonists rewire myeloid stroma in the tumour microenvironment to amplify immune checkpoint blockade efficacy in refractory pancreatic cancer." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 163.08. http://dx.doi.org/10.4049/jimmunol.208.supp.163.08.
Full textChristofides, Anthos, Carol Cao, Qi Wang, Natalia M. Tijaro-Ovalle, Eirini Konstantinidou, Rushil Shah, Chinmay Jani, et al. "Pparα Ablation Suppresses T Cell Responses and Anti-Tumor Immunity By Compromising the Antigen-Presenting Properties of Tumor-Associated Macrophages." Blood 138, Supplement 1 (November 5, 2021): 438. http://dx.doi.org/10.1182/blood-2021-149071.
Full textNguyen-Pham, Thanh-Nhan, Huong Thi Thanh Tran, Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Tai Ju Hwang, Hyeoung-Joon Kim, and Je-Jung Lee. "Potent Immunomodulatory Drug Lenalidomide Synergistically Enhance the Effect of Dendritic Cell Vaccination on Multiple Myeloma in Mouse Model,." Blood 118, no. 21 (November 18, 2011): 3237. http://dx.doi.org/10.1182/blood.v118.21.3237.3237.
Full textSnetsinger, Brooke, Caroline Lin, Willy Weng, Alyssa Cull, Kate Sponagle, Christine Hough, David Lillicrap, and Michael J. Rauh. "Myeloid-Derived Suppressor Cell (MDSC) Dynamics In FVIII-Exposed Hemophilia A Mice: Novel Therapeutic Implications." Blood 122, no. 21 (November 15, 2013): 3569. http://dx.doi.org/10.1182/blood.v122.21.3569.3569.
Full textBoda, Akash, Casey Ager, Kimal Rajapakshe, Spencer Lea, Maria Emilia Di Francesco, Philip Jones, and Michael Curran. "758 High-potency synthetic STING agonists rewire the myeloid stroma in the tumour microenvironment to amplify immune checkpoint blockade efficacy in refractory pancreatic ductal adenocarcinoma." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A793. http://dx.doi.org/10.1136/jitc-2021-sitc2021.758.
Full textLiang, Hua Laura, Enyu Rao, Yuzhu Hou, Jiaai Wang, Xiaona Huang, Xianbin Yu, Liangliang Wang, Chuan He, Everett Vokes, and Ralph Weichselbaum. "Induction of Inflammatory Macrophages in Solid Tumors by All-trans Retinoic Acid Augments Radiation Efficacy." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 118.06. http://dx.doi.org/10.4049/jimmunol.208.supp.118.06.
Full textLee, Jung-Mi, Min-Ji Chae, Young-Jun Park, Yun-Sun Kim, Eun-Kyung Kim, and Chang-Yuil Kang. "Serum amyloid A3 mediates inflammation-related tumor growth by fortifying the immunosuppressive mechanism of myeloid-derived suppressor cells (162.7)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 162.7. http://dx.doi.org/10.4049/jimmunol.188.supp.162.7.
Full textParker, Katherine, and Suzanne Ostrand-Osenberg. "Title: HMGB1 both enhances and blocks myeloid-derived suppressor cell potency Katherine H. Parker, Suzanne Ostrand-Rosenberg Department of Biological Sciences, University of Maryland Baltimore County, Baltimore MD 21250 (162.40)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 162.40. http://dx.doi.org/10.4049/jimmunol.188.supp.162.40.
Full textCimen Bozkus, Cansu, Bennett Elzey, Scott Crist, Lesley Ellies, and Timothy Ratliff. "Expression of cationic amino acid transporter 2 is required for myeloid derived suppressor cell-mediated control of T cell immunity (IRC4P.460)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 57.13. http://dx.doi.org/10.4049/jimmunol.194.supp.57.13.
Full textDing, Chuanlin, and Jun Yan. "Chemotherapy-derived inflammatory responses promote the differentiation and immunosuppressive activity of monocytic-MDSC." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 213.1. http://dx.doi.org/10.4049/jimmunol.196.supp.213.1.
Full textWaight, Jeremy, and Scott Abrams. "Tumor-derived G-CSF promotes granulocytic MDSC development in vivo (66.34)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 66.34. http://dx.doi.org/10.4049/jimmunol.186.supp.66.34.
Full textYan, De hong, Jing hui Wang, and Xiao chun Wan. "TIPE2 is a novel direct target of STAT3 in MDSC and inhibition of its expression on MDSC enhanced T cell activation in tumor." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 205.3. http://dx.doi.org/10.4049/jimmunol.198.supp.205.3.
Full textSinha, Pratima, Olesya Chornoguz, Virginia Clements, Konstantin Artemenko, Roman Zubarev, and Suzanne Ostrand-Rosenberg. "Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL (100.18)." Journal of Immunology 184, no. 1_Supplement (April 1, 2010): 100.18. http://dx.doi.org/10.4049/jimmunol.184.supp.100.18.
Full textBie, Qingli, Pan Zhang, Zhaoliang Su, Dong Zheng, Xinyu Ying, Yumin Wu, Huijian Yang, Deyu Chen, Shengjun Wang, and Huaxi Xu. "Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer." Journal of Immunology Research 2014 (2014): 1–10. http://dx.doi.org/10.1155/2014/923135.
Full textKvell, K., EL Cooper, P. Engelmann, J. Bovari, and P. Nemeth. "Blurring Borders: Innate Immunity with Adaptive Features." Clinical and Developmental Immunology 2007 (2007): 1–10. http://dx.doi.org/10.1155/2007/83671.
Full textChristofides, Anthos, Natalia M. Tijaro-Ovalle, Halil-Ibrahim Aksoylar, Rinku Pal, Abdelrahman AA Mahmoud, Laura Strauss, Nikolaos Patsoukis, and Vassiliki A. Boussiotis. "Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade." Blood 136, Supplement 1 (November 5, 2020): 25–26. http://dx.doi.org/10.1182/blood-2020-138975.
Full textMcGill, Andrew Robert, Tomar Ghansah, Ivannie Ortiz-Rivera, and Cristina Iclozan. "Time-course analysis of SHIP-1 modulation and expression in a pancreatic cancer model." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 211.9. http://dx.doi.org/10.4049/jimmunol.196.supp.211.9.
Full textChaib, Mehdi, Liza Makowski, John Yarbro, Laura Sipe, and Deidre Daria. "682 PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 therapy in breast cancer." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A710. http://dx.doi.org/10.1136/jitc-2021-sitc2021.682.
Full textPetricca, Lydia E., Alexandra R. Witter, Natasha D. Sheybani, Eric A. Thim, Timothy N. Bullock, and Richard J. Price. "Targeting immunosuppression for enhanced focused ultrasound efficacy in triple negative breast cancer." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 117.14. http://dx.doi.org/10.4049/jimmunol.208.supp.117.14.
Full textSmola, Sigrun, Connie Trimble, and Peter L. Stern. "Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy." Therapeutic Advances in Vaccines 5, no. 3 (June 2017): 69–82. http://dx.doi.org/10.1177/2051013617717914.
Full textLee, Hyo Jun, Jiae Koh, and Jongsun Kim. "INF-γ production of NK cells is suppressed in cancer patients. (45.10)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 45.10. http://dx.doi.org/10.4049/jimmunol.188.supp.45.10.
Full textBrock, Rebecca Michaela, Natalie Beitel-White, Alissa Danielle Hendricks, Allison Zeher, Navid Manuchehrabadi, Rafael V. Davalos, and Irving C. Allen. "Irreversible electroporation can alter immune cell composition and enhance antigen presentation potential in pancreatic cancer." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 242.29. http://dx.doi.org/10.4049/jimmunol.204.supp.242.29.
Full textSerafini, Paolo, Kristen Meckel, Michael Kelso, Kimberly Noonan, Joseph Califano, Wayne Koch, Luigi Dolcetti, Vincenzo Bronte, and Ivan Borrello. "Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function." Journal of Experimental Medicine 203, no. 12 (November 13, 2006): 2691–702. http://dx.doi.org/10.1084/jem.20061104.
Full textArkhypov, Ihor, Feyza Gül Özbay Kurt, Rebekka Bitsch, Daniel Novak, Vera Petrova, Samantha Lasser, Thomas Hielscher, et al. "HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling." Journal for ImmunoTherapy of Cancer 10, no. 9 (September 2022): e005551. http://dx.doi.org/10.1136/jitc-2022-005551.
Full textMishra, Alok K., Shahid Banday, Ravi Bharadwaj, Amjad Ali, Romana Rashid, Ankur Kulshreshtha, and Sunil K. Malonia. "Macrophages as a Potential Immunotherapeutic Target in Solid Cancers." Vaccines 11, no. 1 (December 26, 2022): 55. http://dx.doi.org/10.3390/vaccines11010055.
Full textSheybani, Natasha D., Alexandra R. Witter, Eric A. Thim, Hideo Yagita, Timothy N. J. Bullock, and Richard J. Price. "Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity." Journal for ImmunoTherapy of Cancer 8, no. 2 (August 2020): e001008. http://dx.doi.org/10.1136/jitc-2020-001008.
Full textTravés, Paqui G., Alfonso Luque, and Sonsoles Hortelano. "Macrophages, Inflammation, and Tumor Suppressors: ARF, a New Player in the Game." Mediators of Inflammation 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/568783.
Full textSchad, Sara, Daniel Hirschhorn-Cymerman, Sadna Budhu, Hong Zhong, Xia Yang, Taha Merghoub, and Jedd D. Wolchok. "Phosphatidylserine targeting antibody enhances anti-tumor activity of adoptive cell therapies in a mouse melanoma model." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 170.5. http://dx.doi.org/10.4049/jimmunol.204.supp.170.5.
Full textDong, Juan, Cassandra Gilmore, Hieu Ta, Keman Zhang, Sarah Stone, and Li Wang. "501 VISTA regulates the differentiation and suppressive function of myeloid-derived suppressor cells." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A536. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0501.
Full textYu, Xiaolu, Yiru Long, Binfan Chen, Yongliang Tong, Mengwen Shan, Xiaomin Jia, Chao Hu, et al. "PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way." Journal for ImmunoTherapy of Cancer 10, no. 10 (October 2022): e004590. http://dx.doi.org/10.1136/jitc-2022-004590.
Full textHurez, Vincent, Vinh Dao, Aijie Liu, Srilakshmi Pandeswara, Jonathan Gelfond, Lishi Sun, Robert Svatek, et al. "Mammalian target of rapamycin inhibition with enterically given rapamycin alters immunity and gut flora in young and aged wild type mice and extends life of immunodeficient mice (IRC8P.452)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 129.16. http://dx.doi.org/10.4049/jimmunol.194.supp.129.16.
Full textCheng, An Ning, Li-Chun Cheng, Cheng-Liang Kuo, Yu Kang Lo, Han-Yu Chou, Chung-Hsing Chen, Yi-Hao Wang, Tsung-Hsien Chuang, Shih-Jung Cheng, and Alan Yueh-Luen Lee. "Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1–mediated immunoescape via STING-IFN signaling and extracellular vesicles." Journal for ImmunoTherapy of Cancer 8, no. 2 (December 2020): e001372. http://dx.doi.org/10.1136/jitc-2020-001372.
Full textBendell, Johanna, Wells Messersmith, Drew Rasco, Andrea Wang-Gillam, Wungki Park, Lei Zhou, Laura Carter, et al. "388 Preliminary results from KEYNOTE-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A413. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0388.
Full textVoutouri, Chrysovalantis, Corey C. Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin J. Khandekar, Justin F. Gainor, Triantafyllos Stylianopoulos, Lance L. Munn, and Rakesh K. Jain. "Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2." Cancer Immunology Research 10, no. 12_Supplement (December 1, 2022): A64. http://dx.doi.org/10.1158/2326-6074.tumimm22-a64.
Full textSana, Madiha, Muhammad Rashid, Imran Rashid, Haroon Akbar, Jorge E. Gomez-Marin, and Isabelle Dimier-Poisson. "Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response." International Journal of Immunopathology and Pharmacology 36 (January 2022): 039463202210784. http://dx.doi.org/10.1177/03946320221078436.
Full textPeng, Li, Lizhi Cao, Sujata Nerle, Robert LeBlanc, Abhishek Das, Sandip Shelke, Autumn Turner, et al. "843 Development and engineering of human sialidase for degradation of immunosuppressive sialoglycans to treat cancer." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A884. http://dx.doi.org/10.1136/jitc-2021-sitc2021.843.
Full textYang, Tian-Hui, Karen Clise-Dwyer, Gheath Alatrash, Kathryn Ruisaard, Shoudan Liang, and Jeffrey J. Molldrem. "Membrane-Associated Proteinase 3 on Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation." Blood 118, no. 21 (November 18, 2011): 1916. http://dx.doi.org/10.1182/blood.v118.21.1916.1916.
Full textGao, Yuting, Hao Zhou, Gege Liu, Junlu Wu, Yi Yuan, and Anquan Shang. "Tumor Microenvironment: Lactic Acid Promotes Tumor Development." Journal of Immunology Research 2022 (June 12, 2022): 1–8. http://dx.doi.org/10.1155/2022/3119375.
Full textHanamura, Toru, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Banri Tsuda, Takuho Okamura, et al. "Abstract P4-04-09: Systematic analysis of immune cell composition revealed immunological profile of breast cancer microenvironment represented by histologically assessed tumor-infiltrating lymphocyte and PD-L1 expression." Cancer Research 82, no. 4_Supplement (February 15, 2022): P4–04–09—P4–04–09. http://dx.doi.org/10.1158/1538-7445.sabcs21-p4-04-09.
Full textLupo, Kyle, and Sandro Matosevic. "130 Engineered natural killer cells reactively block TIGIT and CD73 in the GBM microenvironment." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A139. http://dx.doi.org/10.1136/jitc-2021-sitc2021.130.
Full textOta, Shuichi, and Masahiro Ogasawara. "Vaccination Of Malignant Lymphoma Patients With WT1 Peptide-Pulsed Dendritic Cells Induces Immunological and Clinical Responses: A Pilot Study." Blood 122, no. 21 (November 15, 2013): 4403. http://dx.doi.org/10.1182/blood.v122.21.4403.4403.
Full textHuang, Tao, Caroline Bonnans, Maria Jose Costa, Azita Tabrizi, Jing-Tyan Ma, Jingjing Xie, Heyu Chen, et al. "304 Antagonistic antibodies targeting LAIR1 enhance T lymphocyte activation and promote inflammatory phenotypes in myeloid cells." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A327. http://dx.doi.org/10.1136/jitc-2021-sitc2021.304.
Full textLee, Je-Jung, Tan-Huy Chu, Manh-Cuong Vo, Hye-Sung Park, Thangaraj Jaya Lakshmi, Seo-Yeon Ahn, Ga-Young Song, Sung-Hoon Jung, and Hyeoung-Joon Kim. "A Combination Therapy with Dendritic Cells, Pomalidomide and Programmed Death-Ligand 1 Blockade Exerts a Potent Antitumor Immunity in a Murine Model of Multiple Myeloma." Blood 134, Supplement_1 (November 13, 2019): 1819. http://dx.doi.org/10.1182/blood-2019-127964.
Full textHao, Xiaoxiao, Chao Zhang, Timothy N. Trotter, Pramod S. Gowda, and Yang Yang. "Abstract A12: Osteocyte apoptosis induces an immunosuppressive microenvironment in bone marrow and promotes myeloma chemoresistance." Cancer Immunology Research 10, no. 12_Supplement (December 1, 2022): A12. http://dx.doi.org/10.1158/2326-6074.tumimm22-a12.
Full textCastella, Barbara, Myriam Foglietta, Patrizia Sciancalepore, Ezio Tripoli, Mario Boccadoro, and Massimo Massaia. "Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients." Blood 128, no. 22 (December 2, 2016): 2059. http://dx.doi.org/10.1182/blood.v128.22.2059.2059.
Full textCarvajal, Luis, Luciana Gneo, Carmela De Santo, Matt Perez, Tracy Garron, Francis Mussai, and Annalisa D’Andrea. "473 Mavrilimumab, a human monoclonal antibody targeting GM-CSFRα, inhibits polarization to myeloid-derived suppressor cells (MDSCs) that express PD-L1 and restores T-cell proliferation in vitro." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A504. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0473.
Full textSanchez-Martin, Marta, Lei Wang, Jeffrey Ecsedy, Karen Mcgovern, and Michelle Zhang. "93 Computational biology and tissue-based approaches to inform indication selection for a novel AHR inhibitor." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A102. http://dx.doi.org/10.1136/jitc-2021-sitc2021.093.
Full textPapadas, Athanasios, Gauri Deb, Adam Officer, Chelsea Hope, Philip Emmerich, Alexander Cicala, Joshua Wiesner, et al. "936 Stromal remodeling regulates dendritic cell abundance in the tumor microenvironment." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A982. http://dx.doi.org/10.1136/jitc-2021-sitc2021.936.
Full text